Related Experiment Video
Updated: Feb 15, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Incremental prognostic value of multichamber deformation imaging and renal function status to predict adverse outcome
Samir K Saha1, Xia-Xia Luo2,3, Aasha S Gopal4
1Umeå University, Umeå, Sweden.
Insights
Biventricular and bi-atrial strain imaging, combined with renal function and pulmonary artery pressure, can predict adverse outcomes in heart failure with reduced ejection fraction. This multichamber approach offers valuable prognostic information for patients with heart failure.
Area of Science:
- Cardiology
- Medical Imaging
- Heart Failure Research
Background:
- Deformation imaging of the heart is crucial in cardiology.
- Limited data exist on biventricular/bi-atrial strain in heart failure with reduced ejection fraction (HFREF) and comorbidities.
Purpose of the Study:
- To investigate the prognostic value of multichamber deformation imaging in HFREF.
- To assess the association of cardiac strain, renal function, and pulmonary artery pressure with adverse outcomes.
Main Methods:
- 49 HFREF patients and 14 controls underwent deformation imaging (LVGLS%, RVS%, LARS%).
- Standard echocardiography (LVEF%, E/E', PASP) and renal function (creatinine) were assessed.
- Logistic regression and ROC analysis evaluated predictors of death/hospitalization over 4.2 years.
Main Results:
- HFREF patients showed significantly impaired LVGLS%, RVS%, and LARS% compared to controls.
- Univariate analysis identified RVS%, E/E', and PASP as predictors of adverse events.
- Multivariate analysis revealed only PASP as an independent predictor; however, LARS% combined with creatinine predicted mortality and hospitalization.
Conclusions:
- Multichamber deformation imaging, renal function, and PASP are valuable for predicting adverse outcomes in HFREF.
- Combining left atrial reservoir strain and renal function offers significant prognostic insight.
Aims:
Deformation imaging, particularly of left-sided heart, is fast becoming an essential tool in clinical cardiology. However, data are scant regarding the value of biventricular and bi-atrial deformation in association with comorbidities in heart failure with reduced left ventricular ejection fraction (HFREF).
Methods And Results:
Forty-nine subjects (72 ± 13 years; 28 male) with HFREF and 14 age-matched controls underwent deformation imaging including LV global longitudinal strain (LVGLS%), right ventricular strain (RVS%), and left atrial reservoir strain (LARS%). Standard echo parameters included LVEF%, E/E' ratio, and pulmonary artery systolic pressure (PASP). Mean ± SD of LVEF, LVGLS%, and RVS% were 31% ± 8%, 7% ± 3%, and 17% ± 7%, respectively, and were significantly lower compared with controls (all P < .0001). Over a follow-up period of 4.2 years, 24% of patients died and 48% had a composite outcome of death and heart failure hospitalization. In the logistic regression model, taking the composite of death and heart failure hospitalization as a dichotomous variable, RVS%, E/E' ratio, and PASP were the only significant univariate predictors of adverse outcome (R2 = .68, all P < .05). In the multivariate model, however, only PASP predicted adverse outcome. PASP also had the largest AUC (0.8) in the ROC analysis. A creatinine level of >88 μmol/L (SCREAT) and a cutoff value of LA reservoir strain (LARS %) at <16.7% provided the best sensitivity (86%) and specificity (40%) with an odds ratio of 3.8. In the Kaplan-Meier survival estimate, LARS%-SCREAT predicted all-cause mortality and HF hospitalization.
Conclusion:
Multichamber deformation imaging along with renal function and PASP could best predict adverse outcome in HFREF.
Related Concept Videos
Predicting Reaction Outcomes
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies

